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SUMMARY
Brown-like adipocytes exist in several adipose depots including white (WAT) as well as brown 
(BAT). Activation of these UCP1+ cells is a potential therapeutic strategy to combat obesity. 
Studies have shown that posttranslational modifications of PPARγ regulate select adipocyte 
programs. Deacetylation of K268 and K293 in the ligand-binding domain of PPARγ by Sirt1 
induces browning of WAT. Phosphorylation of S273 of PPARγ by CDK5 or ERK stimulates a 
diabetogenic program of gene expression in WAT. Here, we report that roscovitine, a CDK 
inhibitor, prevents S273 phosphorylation and promotes formation of UCP1+ (brite) adipocytes in 
WAT. It also enhances energy expenditure as well as prevents diet-induced obesity and insulin 
resistance. Analysis of fluorescence-activated cell-sorted UCP1+ adipocytes shows that the mRNA 
signature of brite adipocytes is distinct from beige adipocytes, which arise through catecholamine 
signaling. These results suggest that brown-like adipocytes in WAT may arise from multiple 
origins.
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INTRODUCTION
Adipose tissue exists within multiple anatomical locations where it functions to control 
energy expenditure as well as regulate many metabolic processes. Excess storage of 
triglycerides (TGs) and other lipids in specific depots, most notably those surrounding the 
internal organs (visceral depots), can lead to insulin resistance, dyslipidemia, fibrosis, and 
cancer. The various depots are composed of an array of cell types including adipocytes as 
well as many others that contribute to the multifaceted function of each depot (Cinti, 2005, 
2012). Adipocytes are generally classified as white and brown, the former storing TGs and 
the latter utilizing lipids to produce heat. White adipocytes deposit TGs in a single large 
lipid droplet (unilocular) that occupies a majority of the cytoplasm. Brown adipocytes have 
multiple lipid droplets (multilocular) and many mitochondria that contain a unique 
uncoupling protein (UCP1) to uncouple electron transport from the generation of ATP for 
heat production (Cannon and Nedergaard, 2004). All adipocytes secrete a plethora of factors 
and hormones that act locally or enter the circulation to contribute to systemic endocrine 
actions (Deng and Scherer, 2010). Various depots can undergo extensive remodeling as the 
organism adapts to energy demands, to stress (i.e., cold) and other responses to maintain 
metabolic homeostasis (Sun et al., 2011). One prominent remodeling process is recruitment 
of brown-like adipocytes to white adipose tissue (WAT) in response to a variety of 
physiological as well as pharmacological effectors (Giordano et al., 2014). These cells 
contain multiple lipid droplets and express thermogenic genes including UCP1. They also 
express genes that are considered markers of white adipocytes at levels significantly lower 
than in visceral white depots (Vernochet et al., 2009). The appearance of these brown-like 
cells in WAT has been observed in many investigations over the last three decades, but 
interest in their potential physiological function has only recently been revisited. This 
primarily is due to the identification of thermogenic tissues in adult humans, which have 
characteristics similar to the brown-like tissue interspersed within mouse WAT and 
activation of this tissue is a potential antiobesity therapy (Farmer, 2009).
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The brown-like cells recruited to WAT through cold exposure arise from progenitors 
expressing TMEM26 and CD137 on their cell surface and are referred to as beige adipocytes 
(Wu et al., 2012). A percentage of these beige cells are derived from smooth muscle-like 
cells that once expressed myosin heavy chain 11 (Myh11). Other brown-like cells can be 
recruited to WAT following exposure to PPARγ ligands (Qiang et al., 2012; Vernochet et al., 
2009). These cells are often referred to as brite adipocytes (Petrovic et al., 2010). The origin 
of these cells is not known. It is possible they are identical to beige cells and stem from the 
same source of progenitors even though the action of the respective inducers is distinct. Cold 
stimulates a β-adrenergic pathway compared to activation of PPARγ. In this regard, it has 
been suggested that brite cells arise through transdifferentiation of pre-existing white 
adipocytes (Giordano et al., 2014).
We previously showed that treatment of mice with a potent PPARγ ligand induced 
expression of brown genes in WAT including UCP1, cidea, and FGF21 but also suppressed 
many visceral white genes including angiotensinogen and chemerin (Vernochet et al., 2009). 
Transcription of many target genes by PPARγ was shown to require repositioning helix 12 
to facilitate association of coactivators in response to ligand binding (Nolte et al., 1998). 
Studies by our group and others further demonstrated that regions of the ligand-binding 
domain other than helix 12 also influenced ligand activity (Liu et al., 2006; Pascual et al., 
2005; Wang et al., 2008). In particular, F372 within helix 7 was shown to be important for 
the ligand-dependent in vitro induction of brown genes as well as suppression of the white 
genes (Wang et al., 2008). Qiang et al. (2012) later showed that deacetylation of K268 and 
K293 in helix 2/3 of PPARγ by Sirt1 is capable of browning WAT and protects mice from 
diet-induced obesity and insulin resistance. Studies by Spiegelman and colleagues have 
shown that phosphorylation of S273 of PPARγ by CDK5 or ERK stimulates a diabetogenic 
program of gene expression (Banks et al., 2015; Choi et al., 2010, 2011). Pharmacological 
inhibition of MEK/ERK prevents S273 phosphorylation, suppresses the diabetogenic genes, 
and improves insulin resistance in obese mice (Banks et al., 2015).
Because S273 is flanked by K268 and K293, we questioned whether phosphorylation of 
S273 also regulates browning of WAT. We show that treatment of mice with a CDK 
inhibitor, roscovitine, browns inguinal WAT (iWAT) to the same extent as rosiglitazone 
treatment. Profiling of RNA from UCP1-positive adipocytes isolated by fluorescence-
activated cell sorting (FACS) from iWAT of mice treated with a β-adrenergic agonist, 
CL316,243 (CL), rosiglitazone (RG), or roscovitine (RS) identifies two distinct populations 
of brown-like cells. Beige (CL316,243) and classic brown adipocytes are closely related, 
while rosiglitazone and roscovitine cells are similar and distinct from the others. All cells 
express UCP1 along with most of the genes associated with thermogenesis and 
mitochondrial activity. The mechanism of browning is consistent with roscovitine preventing 
the phosphorylation of S273 of PPARγ. Taken together, the data show different mechanisms 
of browning WAT give rise to distinct populations of UCP1+ cells suggesting that brown-like 
adipocytes may arise from multiple origins.
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RESULTS
K268 and K293 of PPARγ can be posttranslationally modified to regulate browning of WAT. 
S273 is flanked by these lysines, and when phosphorylated by CDK5 and/or ERK, the 
insulin-sensitizing activity of PPARγ in adipocytes is significantly attenuated. We 
hypothesized that inhibition of S273 phosphorylation would mimic effects of deacetylation 
of K268 and K293 by inducing brown gene expression. Treatment of 3T3-L1 adipocytes 
with roscovitine, a CDK inhibitor, for 1–2 days induced select brown adipocyte mRNAs 
including PRDM16, PGC-1α, FGF21, and UCP1 (Figure 1A) and UCP1 protein (Figure 1C) 
without altering expression of standard adipogenic genes such as adiponectin and FABP4 
(Figure 1B). The drug was shown to be an effective inhibitor of S273 phosphorylation in the 
mature cells (Figure 1D). To investigate whether S273 phosphorylation/dephosphorylation 
of PPARγ determines the browning activity of roscovitine, Swiss 3T3 cell lines expressing 
wild-type and S273A forms of PPARγ were generated. The TNFα-associated 
phosphorylation of S273 of PPARγ in WT cells could be blocked by roscovitine (Figure 
S1A), and, of course, PPARγ could not be phosphorylated at S273 in the mutant cell line 
(Figure 1E). These Swiss cell lines undergo extensive and similar degrees of adipogenesis 
when stimulated with a standard hormonal cocktail consisting of dexamethasone, methyl-
isobutylxanthine, and insulin (Figure S1B). It was not necessary to include a 
thiazolidinedione (TZD), as is the case with many other fibroblast lines. qPCR analysis of 
mRNAs showed equivalent expression of FABP4 and adiponectin in each cell line consistent 
with equivalent adipogenesis (Figure 1F). The S273A cells, however, had enhanced levels of 
brown adipocyte mRNAs including PRDM16 and UCP1 (Figure 1F). Earlier studies by our 
group and others have shown that TZDs can also induce brown gene expression in white 
adipocytes (Petrovic et al., 2010; Vernochet et al., 2009). We questioned, therefore, whether 
the action of TZD is independent of S273 phosphorylation status. Figure 1G shows that TZD 
induces UCP1 protein expression to about the same extent in WT and S273A cells, which is 
to a similar level reached through expression of S273A PPARγ alone. In fact, earlier studies 
by Spiegelman and coworkers suggested that the anti-diabetogenic action of TZDs is, in 
part, through the inhibition of S273 phosphorylation (Choi et al., 2010). We also questioned 
whether the browning activity of roscovitine is through inhibition of S273 phosphorylation. 
The data in Figure 1H demonstrates that roscovitine induces brown genes in WT Swiss-
PPARγ cells to the same extent as S273-PPARγ cells alone, and addition of the drug to 
S273 cells had no additional browning activity. To determine whether the browning activity 
of roscovitine involved selective interaction of PPARγ with brown gene promoters and 
cofactors, we performed two analyses. First, we demonstrate using ChIP-qPCR that both 
roscovitine as well as S273A enhances the binding of PPARγ to the promoters of Pgc1a, 
Ucp1, and Fgf21 genes with no effect on binding to white gene promoters such as retn and 
pank3 (Figure 1I). Second, we immunoprecipitated a MYC-tagged PPARγ from cells 
treated with or without roscovitine and show the drug promotes the interaction of PPARγ 
with PRDM16 and Sirt1 and dissociates its interaction with NCoR1 (Figure 1J). Importantly, 
we show that treatment of mice with roscovitine (RS) for 2 weeks induces expression of 
UCP1 in iWAT to the same extent as treatment with CL316,243 (CL) or rosiglitazone (RG), 
whereas browning only occurs in eWAT in response to CL (Figure 1K). Consistent with the 
in vitro studies, roscovitine prevented the phosphorylation of S273 as well as S112 of 
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PPARγ in both iWAT and eWAT while potently activating MEK/ERK as shown previously 
by others (Banks et al., 2015).
Roscovitine Browns White Adipose Tissue and Enhances Energy Expenditure
These studies strongly support the notion that roscovitine is stimulating the browning 
activity of PPARγ. Studies by Qiang et al. (2012) previously showed that deacetylation of 
PPARγ in mice not only induced browning but also regulates energy homeostasis by 
promoting energy expenditure over storage. To determine whether roscovitine-induced 
browning also affects energy balance, mice were given roscovitine, CL316,243, or 
rosiglitazone every day for 6 weeks at which various physiological parameters were 
measured. Immunohistochemical staining of adipose tissue for UCP1 shows that all three 
agents induced extensive browning of iWAT (Figure 2A) with minimal browning of eWAT 
(Figure S2A). Western blot analysis also showed that the extent of UCP1 expression in 
iWAT is similar for all three treatments (Figure 2B). Fat mass was significantly lower in 
mice treated with roscovitine and CL316,243 compared to control and rosiglitazone-treated 
mice (Figure 2C). Moreover, individual adipocytes were smaller in the eWAT depot of mice 
given roscovitine and CL316,243 (Figure S2A). In all cases, food intake, lean mass, and 
physical activity were the same for the three agents and did not differ from control values 
(Figures 2D–2F). Furthermore, all drug-treated mice exhibited enhanced glucose tolerance 
with CL316,243 being the most potent enhancer (Figure 2G). Only roscovitine and 
CL316,243 suppressed circulating levels of insulin (Figure S2B). The extensive decrease in 
fat mass without a change in food intake or lean mass suggested that roscovitine and 
CL316,243 were enhancing energy expenditure. In fact, analysis of all treated mice in 
Comprehensive Laboratory Animal Monitoring System (CLAMS) metabolic cages showed 
an increase in VCO2 and VO2 (Figures 2H and 2I) in response to roscovitine and 
CL316,243. Rosiglitazone did not increase energy expenditure. The RER values for all 
agents were the same and were consistent with metabolism of a carbohydrate-enriched diet 
(Figure S2C). Importantly, the morphology of BAT and its expression of UCP1 was not 
altered by any of the drugs (Figures 2J and 2K) supporting the notion that roscovitine 
enhances energy expenditure in a BAT-independent manner.
Roscovitine Protects against Diet-Induced Obesity and Insulin Resistance
Next, we questioned whether roscovitine alters the metabolic response to a high fat diet 
(HFD). Mice were given a HFD for 9 weeks and treated with roscovitine, rosiglitazone, or 
CL316,243 every day during the last 6 weeks of the diet. Roscovitine suppressed weight 
gain (Figure 3A) and fat mass (Figure 3B) to a greater extent than the other two drugs 
without any change in lean mass or food intake (Figures 3C and 3D). The HFD resulted in 
hypertrophy of individual adipocytes in iWAT of control and rosiglitazone-treated mice, but 
this was dramatically reduced in response to roscovitine and CL316,243 (Figure 3E). All 
three drugs protected mice from diet-induced inflammation as observed by a corresponding 
loss of crown-like structures in eWAT (Figure 3E). Similarly, all three drugs protected 
against diet-induced glucose intolerance and reduced circulating levels of insulin (Figures 3F 
and 3G). Morphological analysis of the liver demonstrated that the HFD caused steatosis, 
which was only eliminated by treatment with roscovitine (Figure 3H). Rosiglitazone 
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appeared to enhance the deposition of lipids in the liver as reported by others (Rull et al., 
2014).
There is little known about the phenotype of UCP1+ adipocytes residing in WAT following 
treatment of mice with different browning agents. Spiegelman and coworkers have identified 
the origin of UCP1+ cells arising in response to cold exposure and referred to them as beige 
adipocytes (Wu et al., 2012). These cells express gene signatures that reflect the host white 
tissue as well as smooth muscle like genes (Long et al., 2014). To identify the phenotype of 
the brown-like adipocytes induced by roscovitine, rosiglitazone, or CL316,243, we 
generated mice in which UCP1+ adipocytes express GFP, while all other cells including 
white adipocytes express RFP. Figure S3 shows that the BAT depot emits an intense green 
fluorescence while the surrounding white adipose is red in mTmG mice expressing UCP1-
Cre. Visualization of whole mounts of adipose tissue from these mice (Figure 4A) shows the 
presence of small GFP+ cells within the iWAT depot following treatment with CL316,243 
(CL+Cre), roscovitine (RS+Cre), as well as rosiglitazone (RG+Cre). iWAT from untreated 
mice (+Cre) (Figure 4A) as well as control mice lacking the UCP1-cre transgene (data not 
shown) have undetectable levels of GFP fluorescence. To visualize individual adipocytes, the 
respective tissues were digested with collagenase, and total adipocytes floated to the surface 
while stromal vascular cells pelleted following a low speed centrifugation. The adipocytes 
were collected and visualized by fluorescence confocal microscopy. The white adipocytes 
contain an outer rim of intense red fluorescence corresponding to the membrane tethered 
tomato protein (RFP) surrounding a large single lipid droplet. The UCP1+ cells 
corresponding to CL316,243 treatment had a green fluorescent rim (GFP) surrounding 
multiple lipid droplets. Surprisingly, virtually all of the roscovitine-induced UCP1+ 
adipocytes had a green rim around a single or few lipid droplets (Figure 4B). This 
morphology has been termed paucilocular by Giordano et al. (2014).
The recruitment of UCP1+ adipocytes in response to roscovitine could occur through many 
physiological mechanisms. Induction of beige adipocytes by cold is considered to involve 
release of catecholamines through direct and indirect (sympathetic nervous system) means. 
CL316,243, being a potent β-adrenergic agonist, acts in a manner similar to catecholamines 
and, therefore, mimics cold exposure and produces beige cells (Wu et al., 2012). 
Rosiglitazone through its activation of PPARγ has been suggested to stimulate the brown 
gene program in pre-existing preadipocytes or mature adipocytes. The resulting UCP1+ cells 
have been referred to as brite adipocytes (Petrovic et al., 2010). To obtain mRNA signatures 
of each population of UCP1+ adipocytes from WAT, it was necessary to isolate the brown-
like cells from the surrounding white cells. To do this, we established a cell isolation 
procedure in which the adipocyte fraction of collagenase digested adipose tissue of 
UCP1+Cre mice was subjected to fluorescence-activated cell sorting as outlined in the 
Experimental Procedures. Figure 4C shows that GFP-fluorescing (UCP1+) cells (Drugs
+Cre) can be successfully sorted from RFP cells, which consist predominantly of white 
adipocytes (Saline+Cre) because stromal vascular cells have been removed prior to sorting. 
To gain insight into the gene expression signatures of all UCP1+ adipocytes, GFP-positive 
cells were collected by FACS from iWAT of mice treated with CL316,243, rosiglitazone, or 
roscovitine. BAT UCP1+ cells as well as white adipocytes were also harvested from 
untreated mice. qPCR analysis of RNA isolated from all five populations of cells shows 
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similar levels of common adipogenic markers including perilipin, adipsin, adiponectin, and 
aP2 (FABP4) (Figure 4D). The four populations of UCP1+ adipocytes, (BAT, CL, RS, and 
RG), expressed elevated amounts of the common brown genes including UCP1, Otop1, 
PGC1α, Cidea, Elovl3, Cox7a, and Acot11. The RS and RG cells, however, expressed 
several of these brown markers at levels several fold lower than BAT or CL adipocytes as 
shown, particularly for UCP1, Cox7a, and Acot11 (Figure 4E).
Roscovitine Induces Formation of a Unique Population of UCP1+ Adipocytes
To compare the gene signatures of the different cell types, the five RNA samples analyzed in 
Figure 4 (WAT, BAT, CL, RS, and RG) were amplified and subjected to microarray analysis 
(Figure 5). At a global level, the signatures of all five adipocyte types were very similar as 
revealed through pairwise comparisons of each of the samples (Figure S4). In fact, a 
majority (>95%) of RNA sequences are common to all UCP1+ adipocytes including BAT as 
well as white adipocytes. Heatmaps were created of all the genes that had an absolute value 
fold change >2 (Figure 5A). It is very clear that the five signatures are different suggesting 
that the UCP1+ adipocytes are distinct from each other. As an additional approach, principal 
component analysis was performed using all 25,000 probe sets across the five samples. 
These results show that of the UCP1+ adipocyte transcriptomes, the CL316,243 signature is 
closest to that of BAT. The signatures of roscovitine (RS) and rosiglitazone (RG) cells are 
very similar but distinct from that of WAT, BAT, and CL adipocytes (Figure 5B).
To identify potential gene markers for each of the adipocyte types, we analyzed the 
transcriptomes and selected genes whose expression differed 3-fold or greater between the 
cell types. The Venn diagram of the overlapping genes enriched in classical brown 
adipocytes and beige/brite adipocytes versus white adipocytes (Figure 5C) shows that there 
are relatively few mRNAs that can be considered to be cell-type-specific. These few genes 
are presented in the heatmap shown in Figure 5D and some were selected as potential 
markers for each cell type. To validate these selections, we analyzed cell type marker 
expression in RNA isolated from each of the FACS samples by qPCR assays. Some genes 
including Magea1, Nlrp9c, Tdpoz2, Slc22a29, Camsap3, and Kng2 are more highly 
expressed in BAT cells compared to the other UCP1+ adipocytes and can be considered to be 
BAT-selective (Figure 5E). We also found that Arhgdig is expressed predominantly in BAT 
in agreement with Long et al. (2014). Adcy3, Khdrbs3, Phospho1, Ppp1r3b, and Tmem79 
are expressed primarily in BAT and CL316,243 cells compared to all other cells (Figure 5F). 
CL-selective genes include Pcdha3, Scd3, and Trim17 (Figure 5G) while Cdsn, Rhbg, and 
Gpx8 are most abundant in brite (RS and RG) adipocytes (Figure 5I). Examples of genes 
that distinguish RS from RG cells are Tas2r108 (RG-selective) and Sec31b (RS-selective) 
(Figure 5H).
The brite adipocytes (RS and RG) are clearly different from beige cells (CL) both at the 
level of morphology and mRNA signatures. It is conceivable, however, that each population 
arise from the same progenitors, and the brite cells are at an earlier stage of differentiation 
than the beige cells. To test this possibility, we generated two populations of UCP1+ 
adipocytes: immature beige cells by treating mice with CL316,243 for only 3 days and 
mature brite cells by giving roscovitine for 10 days. Figure 6A shows that the immature 
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beige cells have multiple lipid droplets and are significantly smaller than the corresponding 
mature cells after 7 days of CL treatment. They are also significantly different from the 
mature brite cells, which are large, paucilocular cells (Figure 6A, RS+10d). To further 
characterize these UCP1+ cells, we analyzed expression of select mRNAs in 3-day beige 
(CL) and 10-day brite (RS) cells following their isolation by FACS as described in Figure 4. 
Figure 6B shows that both immature beige (CL) and mature brite cells (RS) express levels of 
UCP1 and Acot11 mRNAs many times lower than classic brown adipocytes (BAT). 
Interestingly, the immature beige cells (CL) are capable of expressing the CL-specific 
marker, Trim17, many fold higher than BAT and mature brite (RS) cells. Similarly, the RS 
cells express four of the brite markers (RS or RG), Gpx8, Rhbg, Cdsn, and Sec31b at levels 
significantly higher than all other cells (CL, BAT, or WAT). These data strongly suggest that 
brite cells are not immature beige cells. We also questioned whether the low level of Ucp1 
and Acot11 mRNAs in mature brite cells (Figure 4E) is due to the absence of a thermogenic 
stimulus in the corresponding mice. (The mature beige cells, of course, express Ucp1 
because they constantly receive β-adrenergic stimulation due to the daily injection of mice 
with CL316,243 for 7 days). To address this question, we generated mature brite cells in 
mice by a 10-day treatment with roscovitine and stimulated them with CL316,243 for 3 days 
(R+C in Figure 6B). qPCR analysis was then performed on RNA from FACS UCP1+ cells as 
in Figure 5. It is important to emphasize that this population of UCP1+ cells (R+C) will 
contain both mature brite as well as immature beige cells. It is interesting, therefore, that the 
levels of UCP1 and Acot11 mRNAs are many fold higher in the mixed sample (R+C) than in 
brite (RS) or beige (CL) cells, which were separately analyzed. As expected, the BAT-
specific Kng2 was not induced by CL in the brite cells. A comparison of the relative levels 
of the CL marker (Trim17) with the RS markers (Gpx8, Rhbg, Cdsn, Sec31b) shows that the 
mixed population of UCP1+ cells (R+C) contains significantly more RS than CL cells. 
Taken together, these data show that brite cells (RS) express lower levels of UCP1 as well as 
Acot11 mRNAs because they are not receiving an adequate thermogenic stimulus, but once 
this stimulus is given (CL), these mRNAs are induced in the mature RS cell. The fact that 
CL cells represent a significantly smaller fraction of the mixed R+C population confirms 
that induction of UCP1 and Acot11 mRNAs by CL occurs in pre-existing RS cells.
To demonstrate the functionality of the different UCP1+ adipocytes, we assessed the 
response of mice treated with the browning agents to cold exposure. Mice were pretreated 
with CL, RS, or RG for 10 days at room temperature then moved to the cold room (4°C) for 
3 days. Rectal temperature was measured at outset and every 24 hr. Figure 6C shows that 
mice given the drugs each had higher starting temperatures than control untreated mice with 
CL being the highest. The temperature of mice with brite (RS and RG) and beige (CL) 
adipocytes dropped slightly during the 72-hr cold exposure but not as dramatically as it did 
in control mice. The western blot shown in Figure 6D demonstrates that the response to cold 
correlated with the level of expression of UCP1 in iWAT. Mice treated with the three drugs 
express UCP1 at higher levels than untreated mice consistent with their higher body 
temperatures. Importantly, exposure to cold induced UCP1 expression in the pretreated mice 
many fold higher than cold exposure in untreated mice. These data show that the pre-
existing brite adipocytes respond to a thermogenic stimulus and, in doing so, defend the 
body temperature against cold.
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DISCUSSION
In this report, we present a mouse model that facilitates a detailed molecular analysis of 
UCP1+ adipocytes arising in white adipose tissue of mice treated with different browning 
agents. Roscovitine and rosiglitazone produce UCP1+ cells that have gene expression 
signatures distinct from the signature of beige adipocytes (CL316,243-induced cells). We 
show that roscovitine enhances energy expenditure and protects mice from diet-induced 
obesity and glucose intolerance. Rosiglitazone has no effect on energy balance and only 
protects against diet-induced glucose intolerance. We further demonstrate that roscovitine-
induced browning occurs through mechanisms that are consistent with it blocking the 
phosphorylation of PPARγ at sites previously shown to regulate insulin sensitivity (Choi et 
al., 2010).
Our ability to obtain highly enriched populations of adipocytes from mice treated with 
different browning agents has provided strong evidence for additional types of UCP1+ 
adipocytes besides classical brown and beige cells. Previous classification of these cells is 
based primarily on gene signatures obtained through analysis (microarray and deep 
sequencing) of RNA isolated from adipose tissues. A detailed molecular description of beige 
and brite adipocytes was not possible because the cells reside within a complex environment 
of multiple other cell types including white adipocytes, preadipocytes, vascular, and immune 
cells. To overcome this problem, Spiegelman and coworkers (Long et al., 2014) applied 
translating ribosome affinity purification (TRAP) technology to selectively isolate 
polysomes of UCP1+ cells directly from whole adipose tissue of mice. Analysis of the RNAs 
contained on the polysomes revealed interesting signatures of UCP1+ adipocytes present in 
different white depots. Most notably, their analysis detected a smooth muscle (SM) gene 
expression signature in beige cells but not classical brown adipocytes, which led them to 
show that a small percentage of beige cells arise from smooth muscle like cells that express 
Myh11. The TRAP approach, however, did not detect Tmem26 preferentially in beige cells 
or Zic1 in brown cells, two markers that have been used by many to assign tissue-type 
identity. Long et al. (2014) suggested that a limitation of the TRAP approach is that actively 
translating mRNAs may not completely reflect total mRNAs in beige or brown cells. 
Employing a method that selectively sorts UCP1+ adipocytes from all other cells in the 
brown and white depot has allowed us to obtain gene signatures corresponding to the total 
mRNA population of each of the adipocyte types.
As stated above, the most important outcome of our strategy was to provide evidence for 
existence of different types of UCP1+ adipocytes forming in the subcutaneous white depot in 
response to different browning agents. Roscovitine, rosiglitazone, and CL316,243 produce 
UCP1+ adipocytes that express a common signature of mRNA coding for proteins involved 
in mitochondrial functions and adaptive thermogenesis. There are many differences, 
however, between each of the cell types, suggesting that they might arise from diverse 
origins. The analysis has also identified several genes that are enriched in each cell type that 
have not previously been associated with UCP1+ adipocytes and can now be used as a novel 
set of markers for future classification of each cell type. For example, Cdsn, Rhbg, and 
Gp×8 are much more highly expressed in brite cells (roscovitine and rosiglitazone) than in 
other cell types. Pcdha3, Scd3, and Trim17 are selectively expressed in beige cells while 
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Magea1, Nlrp9c, Tdpoz2, Slc22a29, Camsap3, and Kng2 are primarily expressed in BAT. 
Trim17 is beige cell (CL)-specific. Another interesting and important observation is the 
significant difference in morphology of brite adipocytes compared to beige cells. The former 
are paucilocular, while the latter are multilocular.
We did consider whether brite adipocytes are simply immature beige cells that have not 
reached maturity due to the absence of a β-adrenergic stimulus, which drives beige 
adipogenesis. The data show, however, that immature beige adipocytes are different from 
mature brite cells based on their different patterns of select gene expression (Figure 6). 
Additionally, immature beige cells have an identical overall morphology as their mature 
counterparts (multilocular) except are much smaller in size (data not shown). In contrast, the 
mature brite cells are primarily paucilocular containing few lipid droplets and, in some 
cases, only a single large droplet. Gene expression analysis shows that despite their 
morphological similarity to white cells, they have a distinct mRNA signature. We also 
questioned why expression of UCP1 and other brown genes is so low in brite cells and 
reasoned that the cells are not receiving a thermogenic stimulus. We demonstrate that this is 
the case because addition of CL316,243 to mice already containing abundant numbers of 
brite cells in iWAT induces UCP1 expression in these cells to levels approaching those in the 
BAT depot. It is important to mention that the brite cells still maintain their distinct 
phenotype following the β-adrenergic stimulus (i.e., abundant expression of Gp×8, Rhbg, 
Cdsn, and Sec31b).
The data in Figure 1 suggests that roscovitine induces browning by selectively stimulating 
PPARγ through the inhibition of phosphorylation of S112 and S273. To support this notion, 
we show that expression of S273A PPARγ in Swiss 3T3 cells induces brown adipocyte 
genes. The importance of S273 in bestowing insulin-sensitizing activity on PPARγ was 
originally shown by Spiegelman and coworkers (Choi et al., 2010). They demonstrated that 
S273 is phosphorylated in inflamed adipose tissue, which leads to attenuation of gene 
expression associated with systemic insulin action including adiponectin and adipsin genes. 
Their in vitro studies demonstrated that CDK5 phosphorylates S273, which could be 
blocked by agonist and non-agonist ligands of PPARγ including rosiglitazone. However, 
mice deficient in CDK5 are insulin-resistant rather than the expected insulin-sensitive. This 
turned out to be due to activation of ERK because CDK5 phosphorylates and attenuates the 
activity of MEK1. Furthermore, it was shown that ERK also phosphorylates S273 as well as 
S112: two events that inhibit PPARγ activity. It was subsequently shown that treatment of 
mice with an ERK inhibitor improves insulin-resistance in obese wild-type (WT) and ob/ob 
mice (Banks et al., 2015). Figure 1K shows that roscovitine inhibited phosphorylation of 
S273 and S112 as well as activated the MEK/ERK pathway in adipose tissue. One 
interpretation is that roscovitine inhibits CDK5 activity and somehow prevents ERK from 
phosphorylating PPARγ. The resulting unphosphorylated PPARγ can then induce the 
formation of UCP1+ adipocytes (brite) in the iWAT depot. It is also important to point out 
the close similarity of mRNA signatures of roscovitine- and rosiglitazone-derived UCP1+ 
adipocytes (Figure 5). This provides additional support for the idea that roscovitine browns 
WAT, in part, by selectively activating PPARγ.
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UCP1+ adipocytes recruited to WAT in response to cold or CL316,243 treatment (beige) 
arise from progenitors expressing TMEM26 and CD137 as well as smooth muscle-like 
markers (Long et al., 2014; Wu et al., 2012). The precise origin of the brite adipocytes 
arising due to activation of PPARγ(rosiglitazone and roscovitine), however, is not known. It 
has been proposed that brite cells arise through transdifferentiation of white adipocytes 
(Giordano et al., 2014). The fact that rosiglitazone can induce brown gene expression in 
white adipocytes in culture supports this notion (Vernochet et al., 2009). It is also possible 
that activation of PPARγ redirects the normal differentiation of white preadipocytes to 
brown adipocytes. PPARγ, however, is expressed in other cell types besides preadipocytes 
and adipocytes. Studies by Graff and colleagues show that PPARγ+ progenitors are essential 
for adipose organogenesis, and adult adipocytes fate map to a mural (smooth muscle actin-
positive [SMA+]) cell lineage (Jiang et al., 2014). It is possible that rosiglitazone and 
roscovitine activate the recruitment of PPARγ+/SMA+ progenitors to differentiate into brite 
adipocytes. Both beige and brite cells could arise from the same mural compartment of 
progenitors but have traveled down different pathways due to the nature of their regulators. 
Beige adipogenesis is likely stimulated by factors such as prostaglandin (Vegiopoulos et al., 
2010) released from mature white adipocytes that express β-adrenergic receptors. Brite 
adipogenesis might be driven by stimulation of PPARγ in the mural cells with roscovitine. 
The possibility also exists that PPARγ stimulation could release browning factors from 
white adipocytes. These factors would likely be distinct from those released by CL316,243 
because the resulting UCP1+ adipocytes are different. It will be interesting to see whether 
brite cells can arise from a natural physiological stimulus as is the case with catecholamine 
induction of beige cells. It is conceivable that physiological effectors regulating the post-
translational modification of PPARγ can influence the browning (brite cells) potential of 
WAT under different metabolic conditions. Our identification of selective markers for beige 
(i.e., Trim17) and brite (i.e., Gp×8) cells should aid in the classification of UCP1+ 
adipocytes arising in response to different stimuli.
In conclusion, these studies have provided strong evidence for the recruitment of distinct 
types of UCP1+ adipocytes in WAT by different browning agents. Beige adipocytes that arise 
from a population of progenitors expressing Tmem26 and CD137 can be recruited by cold 
exposure or treatment with β-adrenergic agonists. The brite adipocytes that form in response 
to roscovitine, as well as rosiglitazone, are similar to each other but distinct from beige 
adipocytes. It is not surprising that roscovitine gives rise to adipocytes similar to those 
arising from treatment with rosiglitazone, because the data strongly suggest that the former 
acts by stimulating PPARγ activity. When considering its therapeutic potential, however, 
roscovitine appears to generate a healthier metabolic profile than rosiglitazone. Both drugs 
protect mice from diet-induced glucose intolerance but roscovitine also enhances energy 
expenditure and lowers weight gain. Additionally, roscovitine unlike rosiglitazone or 
CL316,243, prevented diet-induced hepatic steatosis. It is very possible, therefore, that 
roscovitine will not be plagued by the life-threatening side effects associated with 
rosiglitazone therapy. Finally, just as recent studies have used markers of classic brown and 
beige adipocytes to classify adipocytes in the neck and thoracic regions of humans, it will be 
important to include the new set of markers for all UCP1+ adipocytes as presented here.
Wang et al. Page 11
Cell Metab. Author manuscript; available in PMC 2019 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
EXPERIMENTAL PROCEDURES
Plasmids and Cell Lines
Replacement of S273 of PPARγ with alanine and establishment of Swiss 3T3 cell lines 
expressing WT- and S273A-PPARγ, as well as the growth and differentiation of 3T3 L1 
preadipocytes and the PPARγ cell lines, were as previously described (Wang et al., 2008). 
Cells were treated with roscovitine (Cayman Chemical Company) and Troglitazone (Sigma) 
at the times described in the legends of Figures 1 and 2.
Antibodies and Western Blot Analysis
Total cellular protein and tissue samples were extracted and subjected to western blot 
analysis as described (Wang et al., 2008) using antibodies against adiponectin (Thermo 
Scientific), ERK (BD Bioscience), p-ERK (Cell Signaling), PPARγ (Santa Cruz), pS273 
PPARγ (Bioss), pS112PPARg (Abcam), and UCP1 (Abcam).
Animals
C57BL/6N wild-type mice for experiments were obtained from Taconic. UCP1-Cre mice 
and B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (mTmG) mice are 
from Jackson Laboratory. The Ucp1-cre mice were crossed with mTmG mice to remove the 
flox-flanked resistance cassette. Mice were housed at 23°C in a 12 hr light/dark cycle with 
free access to normal chow. All experiments used matched littermates. Experimental 
procedures were approved by the Boston University Institutional Animal Care and Use 
Committee. For diet studies, 8-week-old C57BL/6N wild-type male mice were fed a diet 
with 60% kcal% fat (high fat diet, Research Diets, D12492) for 9 weeks. During the last 6 
weeks of the diet, the mice were intraperitoneally (i.p.) injected daily with rosiglitazone (10 
mg/kg), or roscovitine (50 mg/kg), or CL-316,243 (1 mg/kg), or vehicle. For cold exposure 
experiment, body temperatures were measured rectally using a digital thermometer.
Indirect Calorimetry and Body Composition
For determination of energy expenditure, mice were injected (i.p.) daily with rosiglitazone 
(10 mg/kg), or roscovitine (50 mg/kg), or CL-316,243 (1 mg/kg), or vehicle (−) for 6 weeks. 
Oxygen consumption, carbon dioxide production, RER, food intake, and physical activity 
were measured continuously using Comprehensive Laboratory Animal Monitoring System 
(CLAMS) consisting of open circuit calorimeter and motion detectors. Body composition 
was measured by noninvasive quantitative MRI (EchoMRI700).
Glucose Tolerance Tests and Serum Insulin
Mice were fasted for 6 hr, then blood glucose was measured (Bayer Contour) after tail 
bleeding at 0, 15, 30, 60, and 120 min following an injection of glucose (2 mg/kg body 
weight). Mice were euthanized, and serum obtained from heart blood using serum separation 
tubes (BD) was analyzed using mouse insulin ELISA kit (Crystal Chem).
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Histology
Adipose tissues were excised, fixed in 10% formalin, paraffin-embedded, and sectioned (10-
mm) prior to H&E staining or immunohistochemistry for UCP1 (Abcam; 1:100) detection. 
Signal was detected using the Vector ABC Elite kit.
Confocal Fluorescence Microscopy of Adipose Tissue and Adipocytes
Adipose tissues were excised, washed in PBS twice and cut into tiny pieces, and mounted on 
microscope slides (Fisherfinest). Adipocytes were washed three times with PBS and fixed 
with 3% (w/v) paraformaldehyde in PBS for 20 min at room temperature. Slides were 
prepared and imaged on the same day. Fluorescence micrographs were obtained using a 
Zeiss LSM 710-Live Duo scan at the Cellular Imaging Core at Boston University. 
Background was adjusted using samples from GFP− and/or RFP− littermates, and final 
images were intensity-adjusted using Zen software.
FACS of Adipocyte Subpopulations
Adipocytes were isolated by fractionation of collagenase-digested adipose tissue as outlined 
in detail in the Supplemental Experimental Procedures. Specialized adipocyte FACS strategy 
was developed at the BUSM Flow Cytometry Core Facility. The technical details will be 
available upon request.
Sorting of adipocytes was performed using a BD FACS Aria II high-speed sorter (BD 
Bioscience). A total of 40,000–160,000 living cells per adipocyte group were collected in 
lysis buffer of the RNeasy Plus Micro Kit (QIAGEN) and flash-frozen on dry ice.
RNA Extraction, cDNA Synthesis, and Quantitative Real-Time PCR
Total RNA was extracted from tissues or unsorted cells using Trizol reagent (Invitrogen) 
according to the manufacturer’s instructions. RNA from sorted cells was prepared using the 
RNeasy Plus Micro Kit (QIAGEN). Reverse transcription of RNA from tissues or unsorted 
cells was performed using the High Capacity cDNA Reverse transcription kit (Applied 
Biosystems) with 2,000 ng of RNA. Amplification and reverse transcription of RNA from 
sorted cells was performed using Ambion WT expression kit (Affymetrix) with 50 ng of 
RNA. qPCR was performed on a ViiA 7 (Applied Biosystems), and relative mRNA 
concentrations, which were normalized to 36B4 RNA, were calculated by the ΔΔCt method.
Microarray Analyses of Adipose Tissue Cell Populations
All procedures were performed at the Boston University Microarray & Sequencing Resource 
Facility as described in the GeneChip Whole Transcript (WT) Pico Reagent Kit Manual 
(Affymetrix). Details are outlined in the Supplemental Experimental Procedures. Microarray 
data have been deposited in the GEO: GSE87191.
Statistics
All results are presented as mean ± SD. p values were calculated by unpaired Student’s t test 
(*p < 0.05, **p < 0.01, and ***p < 0.001; p < 0.05 was considered significant throughout). 
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For cultured and primary isolated cells, all experiments were performed independently at 
least three times. Animal studies were from 4–6 animals per group.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Roscovitine inhibits phosphorylation of S273 of PPARγ and induces brown 
adipocyte genes
• Roscovitine browns white fat and enhances energy expenditure
• FACS enrichment of UCP1+ adipocytes enables molecular profiling
• Roscovitine-induced UCP1+ adipocytes are distinct from beige adipocytes
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Figure 1. Roscovitine Enhances Brown Gene Expression in Mature Adipocytes by Inhibiting 
Phosphorylation of S273 of PPARγ
(A) Treatment of 3T3-L1 adipocytes with roscovitine (5 μm) for 1–2 days induced select 
brown adipocyte mRNAs.
(B) Treatment of 3T3-L1 adipocytes with roscovitine (5 μm) for 1–2 days had no effect on 
white adipocyte mRNAs.
(C) Two days of exposure of 3T3-L1 adipocytes to roscovitine increases UCP1 protein 
expression.
(D) Treatment of 3T3-L1 adipocytes for 1 hr with TNFα, roscovitine (RS), or TNFα with 
roscovitine (R+T).
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(E) Western blot of proteins from Swiss WT-PPARγ and S273A-PPARγ adipocytes with or 
without TNFα.
(F) qPCR analysis of RNA from Swiss WT-PPARγ and S273A-PPARγ adipocytes.
(G) Western blot of proteins from Swiss WT-PPARγ and S273A-PPARγ induced to 
differentiate into adipocytes with or without troglitazone (5 mm).
(H) qPCR of RNA from Swiss WT-PPARγ and S273A-PPARγ cells induced to adipocytes 
with (gray) or without (black) roscovitine (5 μM).
(I) Roscovitine (RS) and S273A (SA) selectively enhance the binding of PPARγ to brown 
gene promoters.
(J) Roscovitine (RS) enhances the association of a Myc-tagged PPARγ with Sirt1 and 
PRDM16.
(K) Western blot of proteins from Epi and Ing WAT depots of 8-week-old C57BL/6Nwild-
type male mice that were intraperitoneally (i.p.) injected dailyfor2weeks with vehicle (−), 
CL316,243 (CL), rosiglitazone (RG), or roscovitine (RS).
See also Figure S1.
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Figure 2. Roscovitine Induces Browning of IngWAT and Enhances Energy Expenditure in Mice
(A) UCP1 staining of sections of IngWAT depots from 8-week-old C57BL/6N wild-type 
male mice intraperitoneally (i.p.) injected daily for 6 weeks with roscovitine-RS (50 mg/kg), 
or rosiglitazone-RG (10 mg/kg), or CL-316,243 (1 mg/kg), or vehicle (−), n = 4/group.
(B) Expression of UCP1 protein in the same IngWAT depots analyzed in (A).
(C) Fat weight determined by nuclear magnetic resonance (NMR) (described in the 
Experimental Procedures) of mice from (A).
(D) Lean weight determined by NMR of mice from (A).
(E) Food intake of mice from (A).
(F) Physical activity measured by CLAMS.
(G) After 6 weeks of administration of drugs listed in (A), mice were then i.p. injected with 
glucose at 2 mg/kg of body weight after fasting 6 hr and whole-blood glucose was measured 
at 15, 30, 60, and 120 min.
(H and I) Mice from (A)were housed individually in metabolicchambersfor4daysand 3 
nights. Traces of O2 consumption (I) and CO2 production (H) during 12 hr light anddark 
cycles measured by CLAMS.
(J) UCP1 staining of sections of BAT depots of mice from (A).
(K) Expression of UCP1 protein in the same BAT depots as (J).
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See also Figure S2.
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Figure 3. Roscovitine Protects against Diet-Induced Obesity and Glucose Intolerance
(A) Six-week-old mice were fed a rodent HFD (60% Kcal% fat) for 9 weeks. Three weeks 
into the diet, mice were i.p. injected with rosiglitazone (10 mg/kg), or roscovitine (50 mg/
kg), or CL-316,243 (1 mg/kg) for 6 weeks. Body weight and weight gain were measured at 
weekly intervals, n = 4/group.
(B) Fat weight determined by NMR.
(C) Lean weight determined by NMR.
(D) Food intake was measured every 24 hr.
(E) H&E staining of sections of ING, EPI, and BAT depots from mice in (A) sacrificed at 9 
weeks of diet.
(F) After 6 weeks drug treatment, mice were then i.p. injected with glucose at 2 mg/kg of 
body weight after fasting 6 hrand whole-blood glucose was measured at 15, 30, 60, and 120 
min.
(G) Fasting blood insulin of mice after 9 weeks of HFD.
(H) H&E staining of sections of livers from mice in (E).
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Figure 4. Fluorescence-Activated Cell Sorting of UCP1+ Adipocytes from ING Depots of Mice 
Treated with Different Browning Agents
(A) Confocal fluorescence images of ING, EPI, and BAT depots of 8-week-old UCPI-cre/
Tomato mice injected daily for 2 weeks with CL-316,243 (CL), or roscovitine (RS), or 
rosiglitazone (RG) as in Figure 2A.
(B) Confocal microscopy of single cells in adipocyte suspensions prepared from ING depots 
of mice injected daily for 2 weeks with vehicle (WAT), CL-316,243 (CL), or roscovitine 
(RS).
(C) Representative FACS collection gates for the isolation of UCP1+ adipocytes (GFP) from 
adipose depots of 8-week-old UCP1-cre/Tomato mice injected daily for 2 weeks with 
vehicle or drugs as in (A).
(D) qPCR analysis of select adipogenic mRNAs expressed in WAT (RFP) and RS, RG, CL, 
and BAT (GFP) adipocytes isolated by FACS from ING depot as in (C).
(E) qPCR analysis of select brown marker mRNAs expressed inWAT (RFP) and RS, RG, 
CL, and BAT (GFP) adipocytes isolated by FACS from ING depot as in (C). See also Figure 
S3.
Wang et al. Page 22
Cell Metab. Author manuscript; available in PMC 2019 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 5. Genome-wide mRNA Expression Analyses Identify Distinct Populations of UCP1+ 
Adipocytes in ING WAT of Mice Treated with Different Browning Agents
(A) Heatmaps of microarrays corresponding to RNA from WAT, BAT, CL, RS, and RG 
adipocytes isolated as in Figure 4, n = 3–4/group.
(B) Principle component (PC) analysis of the transcriptome of adipocytes as identified in 
(A).
(C) The overlapping genes enriched by 2-fold or more in mouse classical brown adipocytes, 
mouse beige (CL) or brite adipocytes (RS and RG) versus white adipocytes.
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(D) Heatmap of select genes enriched in each population of adipocytes (WAT, BAT, CL, RS, 
and RG).
(E–I) qPCR analysis of select genes expressed in the different adipocyte types. In each case, 
cells were isolated by FACS to enrich for RFP+ (WAT) or GFP+ (CL, RS, RG, and BAT) 
adipocytes. Genes enriched in: BAT (E); CL and BAT cells (F); CL cells (G); RS or RG cells 
(H); and RS and RG cells (I).
See also Figure S4.
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Figure 6. Roscovitine Induces Formation of a Unique Population of Thermogenic Adipocytes
(A) Confocal images of single adipocytes from UCPI-Cre/Tomato mice treated with 
CL316,243 (CL) for 3 or 7 days or with roscovitine for 10 days (RS) alone or followed by 
CL316,243 for 3 days (RS+CL).
(B) qPCR analysis of genes expressed in FACS isolated adipocytes from (A) (RS, CL, R+C) 
as well as from WAT (Con) and BAT.
(C) Mice were treated with CL, or RG, or RS, or vehicle for 10 days at which stage they 
were housed for 3 days in a cold room. Rectal temperature of control and treated mice was 
measured at outset and every 24 hr in cold room. n = 4/group.
(D) Proteins from drug-treated mice in (C) with and without exposure to cold were analyzed 
by western blot.
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